Miguel León-Arellano

14PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical roboticsInorganic materials (incl. nanomaterials)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 29, 2026
SEPTIN9 Gene Methylation Ratio as Follow-Up Biomarker in Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

|Jun 26, 2026
Adding Preoperative Oral Antibiotics to Mechanical Bowel Preparation Reduces Surgical Site Infections in Elective Colorectal Surgery: A Meta-Analysis of Randomized Controlled Trials.

|Mar 28, 2025
Pre-Treatment SEPTIN9 Gene Methylation Ratio Predicts Tumor Response to Total Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer.

Víctor Domínguez-Prieto, Miguel León-Arellano, Rocío Olivera-Salazar

|Jul 16, 2024
Decalogue for mastering robotic transanal minimally invasive surgery (rTAMIS).

H Guadalajara, M Leon-Arellano, J L Dominguez-Tristancho

|May 26, 2024
Cecum to pelvis technique: a simple and autologous solution to prevent postoperative complications in pelvic surgery.

Hector Guadalajara, Stacye Michelle Toups, Miguel León-Arellano

|Apr 23, 2022
Analysis of Septin 9 Gene Hypermethylation as Follow-Up Biomarker of Colorectal Cancer Patients after Curative Surgery.

Miguel Leon Arellano, Mariano García-Arranz, Héctor Guadalajara

Pageof 3

Frequent Collaborators

8 joint publications

Damián García-Olmo

7 joint publications

Héctor Guadalajara Labajo

2 joint publications

Mariano García-Arranz

2 joint publications

Mariano García-Arranz